cushieblog.com
Osilodrostat Continues to Show Promise for Cushing’s Disease
NEW ORLEANS — The investigational drug osilodrostat (Novartis) continues to show promise for treating Cushing’s disease, now with new phase 3 trial data. The data from the phase 3, multicente…